毒蕈碱型M4受体作为酒精使用障碍治疗靶点:人类与大鼠证据汇聚
该研究通过人类酒精使用障碍(AUD)样本的基因组RNA测序及验证,发现M4毒蕈碱乙酰胆碱受体(mAChR)在壳核而非尾状核下调,并在大鼠模型中验证了M4 mAChR在背外侧纹状体多巴胺D1受体阳性中型棘神经元上的下调。系统性或局部给予M4 mAChR正向变构调节剂VU0467154可减少大鼠酒精自我给药、动机及线索诱导的复吸。
要点
- AUD患者壳核中M4 mAChR基因和蛋白水平下调,尾状核无变化。
- 大鼠长期饮酒模型背外侧纹状体D1受体阳性中型棘神经元上M4 mAChR一致性下调。
- M4正向变构调节剂VU0467154减少大鼠酒精摄入、动机和复吸。
核心结论
- M4 mAChR是治疗酒精使用障碍的潜在治疗靶点。
- 背外侧纹状体D1受体阳性中型棘神经元是介导M4 mAChR对酒精摄入和寻求行为作用的关键部位。
研究设计与样本
- 在人类AUD样本的壳核和尾状核中进行全基因组RNA测序,并采用定量聚合酶链反应和受体结合验证。
- 将候选靶点回译至长期饮酒的大鼠模型,评估大鼠纹状体分子适应的一致性。
- 采用大鼠酒精摄入和寻求行为模型验证潜在治疗靶点。
主要发现
- G蛋白偶联受体是AUD个体中差异调控最显著的经典通路。
- M4 mAChR在AUD样本的壳核中基因和蛋白水平下调,尾状核无下调。
- 大鼠背外侧纹状体D1受体阳性中型棘神经元上M4 mAChR一致性下调。
- 系统性给予VU0467154减少大鼠家庭笼和操作式酒精自我给药、获取酒精的动机及线索诱导的酒精寻求复吸。
- 背外侧纹状体局部微量注射VU0467154减少酒精自我给药和线索诱导的酒精寻求复吸。
临床怎么用
- M4 mAChR正向变构调节可能成为AUD的潜在药物治疗策略,需进一步临床验证。
- 背外侧纹状体D1受体阳性中型棘神经元可作为干预酒精摄入和寻求行为的靶向回路。
局限性
- 人类样本仅检测壳核和尾状核,未覆盖其他脑区。
- 大鼠模型结果需在人类临床试验中验证VU0467154的疗效和安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Alcohol use disorder (AUD) is a major socioeconomic burden on society, and current pharmacotherapeutic treatment options are inadequate. Aberrant alcohol use and seeking alters frontostriatal function. METHODS: We performed genome-wide RNA sequencing and subsequent quantitative polymerase chain reaction and receptor binding validation in the caudate-putamen of human AUD samples to identify potential therapeutic targets. We then back-translated our top candidate targets into a rodent model of long-term alcohol consumption to assess concordance of molecular adaptations in the rat striatum. Finally, we adopted rat behavioral models of alcohol intake and seeking to validate a potential therapeutic target. RESULTS: We found that G protein-coupled receptors were the top canonical pathway differentially regulated in individuals with AUD. The M4 muscarinic acetylcholine receptor (mAChR) was downregulated at the gene and protein levels in the putamen, but not in the caudate, of AUD samples. We found concordant downregulation of the M4 mAChR, specifically on dopamine D1 receptor-expressing medium spiny neurons in the rat dorsolateral striatum. Systemic administration of the selective M4 mAChR positive allosteric modulator, VU0467154, reduced home cage and operant alcohol self-administration, motivation to obtain alcohol, and cue-induced reinstatement of alcohol seeking in rats. Local microinjections of VU0467154 in the rat dorsolateral striatum reduced alcohol self-administration and cue-induced reinstatement of alcohol seeking. CONCLUSIONS: Collectively, these results identify the M4 mAChR as a potential therapeutic target for the treatment of AUD and the D1 receptor-positive medium spiny neurons in the dorsolateral striatum as a key site mediating the actions of M4 mAChR in relation to alcohol consumption and seeking.
引用
- Walker LC, Berizzi AE, Chen NA, et al. Acetylcholine Muscarinic M4 Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents. Biol Psychiatry. 2020. PMID: 32331824. doi:10.1016/j.biopsych.2020.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。